Decreasing Prescription Copays Increases Adherence
- 00:02:34
- Icyou
Decreasing Prescription Copays Increases Adherence
Lowering copayments for prescription drugs encourages patients to remain on recommended medication therapies for chronic conditions, according to a recent study. The one year investigation, “The Impact of Decreasing Copayments on Medication Adherence in the Context of a Disease Management Program,” was co-funded by GlaxoSmithKline (GSK). It examined the impact of decreasing copayments for medicines used to treat several chronic diseases. The study focused on the employees of a leading service industry company, and indicates that by reducing copayment rates for generic medications from $5 to $0 and halving the amounts for branded drugs, there was a statistically significant improvement in adherence to treatment for heart disease, diabetes, and high cholesterol. Infrequent use of a medication regimen is a serious problem, GSK reports, and can result in substantial worsening of a disease and overall health care costs. www.gsk.com
Icyou | January 18, 2008
NEW SURVEY REVEALS THAT 74 PERCENT OF CONSUMERS DON'T TAKE P
Unemployment reaches an 11-year-high
Diabetes Ten City Challenge Interim Results Show Improved Patient Health Across Key Clinical and Patient Satisfaction Indicators
Diabetes Ten City Challenge Interim Results Show Improved Patient Health Across Key Clinical and Patient Satisfaction Indicators
Diabetes Ten City Challenge Interim Results Show Improved Patient Health Across Key Clinical and Patient Satisfaction Indicators
Diabetes Ten City Challenge Interim Results Show Improved Patient Health Across Key Clinical and Patient Satisfaction Indicators
